Clinical trial
The LightPath® and 68Ga-RM2 in Breast Cancer Study
NCT03731026
Study timeline
Study start (estimated)2018-11-30Date precision: day
Registry last updated2018-11-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
LightPath® Imaging System and 68Ga-RM2COMBINATION_PRODUCT
68Ga-RM2DRUG
Sponsors & collaborators
Lightpoint Medical Limitedlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03731026 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.